Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

CALONGE COMMENTS.

Calonge N.

Am J Public Health. 2019 May;109(5):707-708. doi: 10.2105/AJPH.2019.305024. No abstract available.

PMID:
30969832
2.

Cost Effectiveness of Age-Specific Screening Intervals for People With Family Histories of Colorectal Cancer.

Naber SK, Kuntz KM, Henrikson NB, Williams MS, Calonge N, Goddard KAB, Zallen DT, Ganiats TG, Webber EM, Janssens ACJW, van Ballegooijen M, Zauber AG, Lansdorp-Vogelaar I.

Gastroenterology. 2018 Jan;154(1):105-116.e20. doi: 10.1053/j.gastro.2017.09.021. Epub 2017 Sep 28.

3.

Is It Time for the USPSTF to Inform-But Not Determine-Coverage?

Moyer VA, LeFevre M, Calonge N.

Ann Intern Med. 2016 Dec 20;165(12):876-877. doi: 10.7326/M16-2304. Epub 2016 Oct 11. No abstract available.

PMID:
27723869
4.

Recommendation to Reduce Patients' Blood Pressure and Cholesterol Medication Costs.

Fielding JE, Rimer BK, Johnson RL, Orleans CT, Calonge N, Clymer JM, Glanz K, Goetzel RZ, Green LW, Ramirez G, Pronk NP; Community Preventive Services Task Force.

Prev Chronic Dis. 2015 Nov 25;12:E209. doi: 10.5888/pcd12.150253. Review. No abstract available.

5.

Family history and the natural history of colorectal cancer: systematic review.

Henrikson NB, Webber EM, Goddard KA, Scrol A, Piper M, Williams MS, Zallen DT, Calonge N, Ganiats TG, Janssens AC, Zauber A, Lansdorp-Vogelaar I, van Ballegooijen M, Whitlock EP.

Genet Med. 2015 Sep;17(9):702-12. doi: 10.1038/gim.2014.188. Epub 2015 Jan 15. Review.

6.

Developing evidence-based screening recommendations, with consideration for rheumatology.

Calonge N.

Rheum Dis Clin North Am. 2014 Nov;40(4):787-95. doi: 10.1016/j.rdc.2014.07.016. Epub 2014 Sep 13. Review.

PMID:
25437292
7.

Evidence synthesis and guideline development in genomic medicine: current status and future prospects.

Schully SD, Lam TK, Dotson WD, Chang CQ, Aronson N, Birkeland ML, Brewster SJ, Boccia S, Buchanan AH, Calonge N, Calzone K, Djulbegovic B, Goddard KA, Klein RD, Klein TE, Lau J, Long R, Lyman GH, Morgan RL, Palmer CG, Relling MV, Rubinstein WS, Swen JJ, Terry SF, Williams MS, Khoury MJ.

Genet Med. 2015 Jan;17(1):63-7. doi: 10.1038/gim.2014.69. Epub 2014 Jun 19.

8.

Immunization information systems to increase vaccination rates: a community guide systematic review.

Groom H, Hopkins DP, Pabst LJ, Murphy Morgan J, Patel M, Calonge N, Coyle R, Dombkowski K, Groom AV, Kurilo MB, Rasulnia B, Shefer A, Town C, Wortley PM, Zucker J; Community Preventive Services Task Force.

J Public Health Manag Pract. 2015 May-Jun;21(3):227-48. doi: 10.1097/PHH.0000000000000069. Review.

PMID:
24912082
9.

Characterizing genetic variants for clinical action.

Ramos EM, Din-Lovinescu C, Berg JS, Brooks LD, Duncanson A, Dunn M, Good P, Hubbard TJ, Jarvik GP, O'Donnell C, Sherry ST, Aronson N, Biesecker LG, Blumberg B, Calonge N, Colhoun HM, Epstein RS, Flicek P, Gordon ES, Green ED, Green RC, Hurles M, Kawamoto K, Knaus W, Ledbetter DH, Levy HP, Lyon E, Maglott D, McLeod HL, Rahman N, Randhawa G, Wicklund C, Manolio TA, Chisholm RL, Williams MS.

Am J Med Genet C Semin Med Genet. 2014 Mar;166C(1):93-104. doi: 10.1002/ajmg.c.31386. Epub 2014 Mar 13.

10.

Researching together: a CTSA partnership of academicians and communities for translation.

Westfall JM, Nearing K, Felzien M, Green L, Calonge N, Pineda-Reyes F, Jones G, Tamez M, Miller S, Kramer A.

Clin Transl Sci. 2013 Oct;6(5):356-62. doi: 10.1111/cts.12063. Epub 2013 Jun 3.

11.

Decision-making process for conditions nominated to the recommended uniform screening panel: statement of the US Department of Health and Human Services Secretary's Advisory Committee on Heritable Disorders in Newborns and Children.

Kemper AR, Green NS, Calonge N, Lam WK, Comeau AM, Goldenberg AJ, Ojodu J, Prosser LA, Tanksley S, Bocchini JA Jr.

Genet Med. 2014 Feb;16(2):183-7. doi: 10.1038/gim.2013.98. Epub 2013 Aug 1.

PMID:
23907646
12.
13.

Population-based versus practice-based recall for childhood immunizations: a randomized controlled comparative effectiveness trial.

Kempe A, Saville A, Dickinson LM, Eisert S, Reynolds J, Herrero D, Beaty B, Albright K, Dibert E, Koehler V, Lockhart S, Calonge N.

Am J Public Health. 2013 Jun;103(6):1116-23. doi: 10.2105/AJPH.2012.301035. Epub 2012 Dec 13.

14.

Improving the efficiency and relevance of evidence-based recommendations in the era of whole-genome sequencing: an EGAPP methods update.

Veenstra DL, Piper M, Haddow JE, Pauker SG, Klein R, Richards CS, Tunis SR, Djulbegovic B, Marrone M, Lin JS, Berg AO, Calonge N.

Genet Med. 2013 Jan;15(1):14-24. doi: 10.1038/gim.2012.106. Epub 2012 Sep 6. Review.

15.

Commentary: adding realism and perspective to behavioral counseling curricula for medical students.

Campos-Outcalt D, Calonge N.

Acad Med. 2012 Jul;87(7):840-1. doi: 10.1097/ACM.0b013e3182580f56.

PMID:
22735559
16.

EDM forum supplement overview.

Calonge N.

Med Care. 2012 Jul;50 Suppl:S1-2. doi: 10.1097/MLR.0b013e3182588ef7.

PMID:
22692251
17.

Clinical and community prevention and treatment service for depression: a whole greater than the sum of its parts.

Calonge N.

Am J Prev Med. 2012 May;42(5):556-7. doi: 10.1016/j.amepre.2012.01.015. No abstract available.

PMID:
22516499
18.

Reconsidering the criteria for evaluating proposed screening programs: reflections from 4 current and former members of the U.S. Preventive services task force.

Harris R, Sawaya GF, Moyer VA, Calonge N.

Epidemiol Rev. 2011;33:20-35. doi: 10.1093/epirev/mxr005. Epub 2011 Jun 10.

PMID:
21666224
19.

[Before and after glomerular filtration].

Cervera M, CallĂ­s M, Calonge N, Zurita M, Franquesa L, Galan S.

Aten Primaria. 2011 Oct;43(10):561. doi: 10.1016/j.aprim.2010.09.028. Epub 2011 Apr 27. Spanish. No abstract available.

20.

Media coverage of U.S. preventive services task force recommendations: a commentary.

Petitti DB, Calonge N.

Am J Prev Med. 2011 May;40(5):579-80. doi: 10.1016/j.amepre.2011.02.009. No abstract available.

PMID:
21496760
21.

USPSTF erroneously understated life-years-gained benefit of mammographic screening of women in their 40s.

Helvie MA, Petitti DB, Calonge N, Melnyk BM, Wilt TJ.

Radiology. 2011 Mar;258(3):958-9. doi: 10.1148/radiol.101705. No abstract available.

PMID:
21339356
22.

Mammography screening for breast cancer: recommendation of the U.S. Preventive Services Task Force.

LeFevre ML, Calonge N, Dietrich AJ, Melnikow J.

Am Fam Physician. 2010 Sep 15;82(6):602, 609. No abstract available.

23.

Breast cancer screening: from science to recommendation.

Petitti DB, Calonge N, LeFevre ML, Melnyk BM, Wilt TJ, Schwartz JS; U.S. Preventive Services Task Force.

Radiology. 2010 Jul;256(1):8-14. doi: 10.1148/radiol.10100559. No abstract available.

PMID:
20574080
24.

Editorial comment.

Wilt TJ, Calonge N.

Urology. 2010 May;75(5):1129-30; author reply 1130. doi: 10.1016/j.urology.2009.10.074. No abstract available.

PMID:
20451733
25.

Mammography in younger women: the dilemma of diminishing returns.

Calonge N.

J Natl Cancer Inst. 2010 May 19;102(10):668-9. doi: 10.1093/jnci/djq137. Epub 2010 May 3. No abstract available.

PMID:
20439837
26.

Committee report: Method for evaluating conditions nominated for population-based screening of newborns and children.

Calonge N, Green NS, Rinaldo P, Lloyd-Puryear M, Dougherty D, Boyle C, Watson M, Trotter T, Terry SF, Howell RR; Advisory Committee on Heritable Disorders in Newborns and Children.

Genet Med. 2010 Mar;12(3):153-9. doi: 10.1097/GIM.0b013e3181d2af04.

PMID:
20154628
27.

The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Initiative: methods of the EGAPP Working Group.

Teutsch SM, Bradley LA, Palomaki GE, Haddow JE, Piper M, Calonge N, Dotson WD, Douglas MP, Berg AO; EGAPP Working Group.

Genet Med. 2009 Jan;11(1):3-14. doi: 10.1097/GIM.0b013e318184137c.

28.

Expanding newborn screening: process, policy, and priorities.

Moyer VA, Calonge N, Teutsch SM, Botkin JR; United States Preventive Services Task Force.

Hastings Cent Rep. 2008 May-Jun;38(3):32-9.

PMID:
18581935
29.

Screening for familial hypercholesterolaemia.

Calonge N, Guirguis-Blake J.

BMJ. 2007 Sep 22;335(7620):573-4. No abstract available.

30.

Current processes of the U.S. Preventive Services Task Force: refining evidence-based recommendation development.

Guirguis-Blake J, Calonge N, Miller T, Siu A, Teutsch S, Whitlock E; U.S. Preventive Services Task Force.

Ann Intern Med. 2007 Jul 17;147(2):117-22. Epub 2007 Jun 18.

PMID:
17576998
31.

How to read the new recommendation statement: methods update from the U.S. Preventive Services Task Force.

Barton MB, Miller T, Wolff T, Petitti D, LeFevre M, Sawaya G, Yawn B, Guirguis-Blake J, Calonge N, Harris R; U.S. Preventive Services Task Force.

Ann Intern Med. 2007 Jul 17;147(2):123-7. Epub 2007 Jun 18.

PMID:
17576997
33.

The response to an allegation of scientific misconduct in the Bucci et al. article on DIMP exposure in mink.

Calonge N.

Reprod Toxicol. 2006 Oct;22(3):553; author reply 555. Epub 2006 May 4. No abstract available.

PMID:
16677800
34.

The pacifier debate.

Calonge N, Petitti D.

Pediatrics. 2006 May;117(5):1849-50; author reply 1850-3. No abstract available.

PMID:
16651350
35.

Screening for testicular cancer: recommendation statement.

Calonge N; U.S. Preventive Services Task Force Agency for Healthcare Research and Quality.

Am Fam Physician. 2005 Nov 15;72(10):2069-70. No abstract available.

36.

Screening for HCV infection: understanding the USPSTF recommendation.

Randhawa GS, Calonge N.

Am Fam Physician. 2005 Aug 15;72(4):579-80. No abstract available.

37.

Community interventions to prevent violence: translation into public health practice.

Calonge N.

Am J Prev Med. 2005 Feb;28(2 Suppl 1):4-5. No abstract available.

PMID:
15698744
38.

The meaning of the U.S. Preventive Services Task Force grade I recommendation: screening for hepatitis C virus infection.

Calonge N, Randhawa G; U.S. Preventive Services Task Force.

Ann Intern Med. 2004 Nov 2;141(9):718-9.

PMID:
15520429
39.

Screening for syphilis infection: recommendation statement.

Calonge N; U.S. Preventive Services Task Force.

Ann Fam Med. 2004 Jul-Aug;2(4):362-5. No abstract available. Erratum in: Ann Fam Med. 2004 Sep-Oct;2(5):517.

40.

Screening for family violence: what's an evidence-based doctor to do?

Calonge N.

Ann Intern Med. 2004 Jul 6;141(1):82-3. No abstract available.

PMID:
15238387
41.

Prevention of dental caries in preschool children: recommendations and rationale.

Calonge N; U.S. Preventive Services Task Force.

Am J Prev Med. 2004 May;26(4):326-9. No abstract available.

PMID:
15110060
42.

Validity of women's self-reports of cancer screening test utilization in a managed care population.

Caplan LS, McQueen DV, Qualters JR, Leff M, Garrett C, Calonge N.

Cancer Epidemiol Biomarkers Prev. 2003 Nov;12(11 Pt 1):1182-7.

44.

New USPSTF guidelines: integrating into clinical practice. US Preventive Services Task Force.

Calonge N.

Am J Prev Med. 2001 Apr;20(3 Suppl):7-9. No abstract available.

PMID:
11306226
45.

Validation of self-reported chronic conditions and health services in a managed care population.

Martin LM, Leff M, Calonge N, Garrett C, Nelson DE.

Am J Prev Med. 2000 Apr;18(3):215-8.

PMID:
10722987
46.

Validity of self-reported colorectal cancer screening behavior.

Baier M, Calonge N, Cutter G, McClatchey M, Schoentgen S, Hines S, Marcus A, Ahnen D.

Cancer Epidemiol Biomarkers Prev. 2000 Feb;9(2):229-32.

47.
48.

Promoting cancer screening among the first-degree relatives of breast and colorectal cancer patients: the design of two randomized trials.

Marcus AC, Ahnen D, Cutter G, Calonge N, Russell S, Sedlacek SM, Wood M, Manchester D, Fox L, McCaskill-Stevens W, Fairclough D, Hines S, Wenzel L, Osborn K.

Prev Med. 1999 Mar;28(3):229-42.

PMID:
10072740
49.
50.

Randomized controlled study of customized preventive medicine reminder letters in a community practice.

Hogg WE, Bass M, Calonge N, Crouch H, Satenstein G.

Can Fam Physician. 1998 Jan;44:81-8.

Supplemental Content

Loading ...
Support Center